SCHEMBL20242536

SCHEMBL20242536

CS(=O)(=O)c1ccc(N2CCN(CCO)CC2)cc1NC(c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.49
ACHE P22303 1/20 0.47
HTT P42858 1/20 0.46
RORC P51449 1/20 0.43
MAPT P10636 6/20 0.42
MAPK1 P28482 2/20 0.42
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 1/20 0.41
DRD2 P14416 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 2/20 0.41
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
GAA P10253 1/20 0.40
CHRM2 P08172 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20242508 0.90 ACHE (0.47) HTR6ACHEHTTRORCMAPT
SCHEMBL20242151 0.88 ACHE (0.50) HTR6ACHEMAPTMAPK1ALDH1A1
SCHEMBL20242365 0.87 HTR6 (0.47) HTR6MAPTMAPK1ALDH1A1KMT2A
SCHEMBL20242467 0.87 HTR6 (0.64) HTR6ACHEMAPTMAPK1ALDH1A1
SCHEMBL20242472 0.86 HTR6 (0.47) HTR6HTTRORCMAPTMAPK1
SCHEMBL20242534 0.83 HTR6 (0.48) HTR6HTTMAPTMAPK1ALDH1A1
SCHEMBL20242180 0.83 HTR6 (0.45) HTR6HTTRORCMAPTMAPK1
SCHEMBL21378916 0.83 HTR6 (0.50) HTR6HTTMAPTMAPK1ALDH1A1
SCHEMBL20242252 0.83 HTR6 (0.50) HTR6ACHEHTTMAPTMAPK1
SCHEMBL20242670 0.81 HTR6 (0.57) HTR6MAPTMAPK1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11459308-B2 Broad spectrum inhibitors of filoviruses MICROBIOTIX, INC. (US) 2022-10-04 US claimed
US-20190292165-A1 BROAD SPECTRUM INHIBITORS OF FILOVIRUSES MICROBIOTIX, INC. (US) 2019-09-26 US claimed
US-11459308-B2 Broad spectrum inhibitors of filoviruses MICROBIOTIX, INC. (US) 2022-10-04 US disclosed
EP-3548034-A1 BROAD-SPECTRUM INHIBITORS OF FILOVIRUSES Microbiotix, Inc. (US) 2019-10-09 EP disclosed
US-20190292165-A1 BROAD SPECTRUM INHIBITORS OF FILOVIRUSES MICROBIOTIX, INC. (US) 2019-09-26 US disclosed
WO-2018106667-A1 BROAD-SPECTRUM INHIBITORS OF FILOVIRUSES MICROBIOTIX, INC. (US) 2018-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11459308-B2 Broad spectrum inhibitors of filoviruses NPC1L1, NPC1, GBA1 HTR6 4498/4885ACHE 4669/4885HTT 3781/4885
US-20190292165-A1 BROAD SPECTRUM INHIBITORS OF FILOVIRUSES NPC1L1, NPC1, GBA1 HTR6 4498/4885ACHE 4669/4885HTT 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.